S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 30 of 94

Issue Date	Title / Author(s) / Citation	File
2023-10	Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo Kim, Jin-Soo; Kim, Mi Young; Hong, Sungyoul Cancers, Vol.15 No.19, p. 4768	DOI
2022-12	Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK plus Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study Ahn, Myung J.; Kim, Hye R.; Yang, James C. H.; Han, Ji-Yu; Li, Jacky Yu-Chung; Hochmair, Maximilian J.; Chang, Gee-Chen; Delmonte, Angelo; Lee, Ki H.; Campelo, Rosario G.; Gridelli, Cesare; Spira, Alexander, I; Califano, Raffaele; Griesinger, Frank; Ghosh, Sharmistha; Felip, Enriqueta; Kim, Dong-Wan; Liu, Yuyin; Zhang, Pingkuan; Popat, Sanjay; Camidge, D. Ross Clinical Lung Cancer, Vol.23 No.8, pp.720-730	DOI
2022-09	Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer: Results of a phase 2, single-arm, open-label study Tan, Daniel S.W.; Kim, Sang-We; Ponce Aix, Santiago; Sequist, Lecia V.; Smit, Egbert F.; Yang, James C.H.; Hida, Toyoaki; Toyozawa, Ryo; Felip, Enriqueta; Wolf, Juergen; Grohé, Christian; Leighl, Natasha B.; Riely, Gregory; Cui, Xiaoming; Zou, Mike; Ghebremariam, Samson; O'Sullivan-Djentuh, Leslie; Belli, Riccardo; Giovannini, Monica; Kim, Dong-Wan European Journal of Cancer, Vol.172, pp.276-286	DOI
2022-07	A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer Cho, Byoung Chul; Goldberg, Sarah B.; Kim, Dong-Wan; Socinski, Mark A.; Burns, Timothy F.; Lwin, Zarnie; Pathan, Nuzhat; Ma, Wei Dong; Masters, Joanna C.; Cossons, Nandini; Wilner, Keith; Nishio, Makoto; Husain, Hatim Expert Opinion on Investigational Drugs, Vol.31 No.7, pp.747-757
2021-12	Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Campelo, D. h Maria Rosario Garcia; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander I.; Gettinger, Scott N.; Tiseo, Marcello; Lin, Huamao M.; Liu, Yuyin; Vranceanu, Florin; Niu, Huifeng; Zhang, Pingkuan; Popat, Sanjay Journal of Thoracic Oncology, Vol.16 No.12, pp.2091-2108	DOI
2021-05	Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study Park, Keunchil; Janne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Kang, Jin-Hyoung; Lee, Dae Ho; Cho, Byoung Chul; Yu, Chong-Jen; Pang, Yong Kek; Felip, Enriqueta; Kim, Hyunjin; Baek, Eunhye; Noh, Young Su Cancer, Vol.127 No.9, pp.1407-1416	DOI
2021-02	TGFβ promotes YAP-dependent AXL induction in mesenchymal-type lung cancer cells Choi, Jeong-Yun; Lee, Haeseung; Kwon, Eun-Ji; Kong, Hyeon-Joon; Kwon, Ok-Seon; Cha, Hyuk-Jin Molecular Oncology, Vol.15 No.2, pp.679-696	DOI
2021-01	LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p Ku, Gwan Woo; Kang, Yujin; Yu, Seong-Lan; Park, Joonghoon; Park, Sejin; Jeong, In Beom; Kang, Min Woong; Son, Ji Woong; Kang, Jaeku BMC Cancer. 2021 Jan 09;21(1):44	view file DOI
2021-01	LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p Ku, Gwan Woo; Kang, Yujin; Yu, Seong-Lan; Park, Joonghoon; Park, Sejin; Jeong, In Beom; Kang, Min Woong; Son, Ji Woong; Kang, Jaeku BMC Cancer, Vol.21 No.1, p. 44	DOI
2020-11	Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Garcia Campelo, Maria Rosario; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Lin, Huamao M.; Gupta, Neeraj; Hanley, Michael J.; Ni, Quanhong; Zhang, Pingkuan; Popat, Sanjay Journal of Clinical Oncology, Vol.38 No.31, pp.3592-3603	DOI
2019-10	The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab Shin, Jung Won; Kim, Soohyun; Ha, Suji; Choi, Byungsan; Kim, Seongyeong; Im, Seock-Ah; Yoon, Tae-Young; Chung, Junho Biomolecules, Vol.9 No.10, p. 629	DOI
2019-09	GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer Park, Ji Eun; Jin, Mei Hua; Hur, Minkyu; Nam, Ah-Rong; Bang, Ju-Hee; Won, Jonghwa; Oh, Do-Youn; Bang, Yung-Jue Gastric Cancer, Vol.22 No.5, pp.932-940	DOI
2019-07	Acquired resistance of MET-amplified non-small cell lung cancer cells to the MET inhibitor capmatinib Kim, Seulki; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Kim, Miso; Alm, Yong-Oon; Keam, Bhumsuk; Heo, Dae Seog Cancer Research and Treatment, Vol.51 No.3, pp.951-962	view file DOI
2019-06	First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression Schuler, Martin; Tan, Eng-Huat; O'Byrne, Kenneth; Zhang, Li; Boyer, Michael; Mok, Tony; Hirsh, Vera; Yang, James Chih-Hsin; Lee, Ki Hyeong; Lu, Shun; Shi, Yuankai; Kim, Sang-We; Laskin, Janessa; Kim, Dong-Wan; Arvis, Catherine Dubos; Kolbeck, Karl; Massey, Dan; Maerten, Angela; Paz-Ares, Luis; Park, Keunchil Journal of Cancer Research and Clinical Oncology, Vol.145 No.6, pp.1569-1579	DOI
2019-06	NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors Park, Ha-Ram; Ahn, Yong-Oon; Kim, Tae Min; Kim, Soyeon; Kim, Seulki; Lee, Yu Soo; Kim, Miso; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog Cytotherapy, Vol.21 No.6, pp.603-611	DOI
2019-05	Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M-Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report Yang, James Chih-Hsin; Shepherd, Frances A.; Kim, Dong-Wan; Lee, Gyeong-Won; Lee, Jong Seok; Chang, Gee-Chen; Lee, Sung Sook; Wei, Yu-Feng; Lee, Yun Gyoo; Laus, Gianluca; Collins, Barbara; Pisetzky, Francesca; Horn, Leora Journal of Thoracic Oncology, Vol.14 No.5, pp.933-939	DOI
2019-01	Epidermal growth factor receptor gene amplification predicts worse outcome in patients with surgically resected nonadenocarcinoma lung cancer Chang, Hyun; Yang, Yaewon; Lee, Jong-Seok; Jheon, Sang-Hoon; Kim, Yu Jung; Chung, Jin-Haeng Clinical Lung Cancer, Vol.20 No.1, pp.7-12.e1	DOI
2019-01	The risk of herpes zoster in patients with non-small cell lung cancer according to chemotherapy regimens: Tyrosine kinase inhibitors versus cytotoxic chemotherapy Choi, Ji Young; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Jo, Seong Jin Cancer Research and Treatment, Vol.51 No.1, pp.169-177	view file DOI
2018-11	Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James Chih-Hsin -H.; Han, Ji-Youn; Lee, Jong-Seok; Hochmair, Maximilian J.; Li, Jacky Yu-Chung; Chang, Gee-Chen; Lee, Ki Hyeong; Gridelli, Cesare; Delmonte, Angelo; Garcia Campelo, Rosario; Kim, Dong-Wan; Bearz, Alessandra; Griesinger, Ffrank; Morabito, Alessandro; Felip, Enriqueta; Califano, Raffaele; Ghosh, Sharmistha; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Gupta, Neeraj; Haney, Jeff; Kerstein, David; Popat, Sanjay New England Journal of Medicine, Vol.379 No.21, pp.2027-2039	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2018-02	PartⅠ: Selective O-alkylation based practical and efficient synthesis of Gefitinib, an EGFR kinase inhibitor PartⅡ: Practical synthesis of Levocabastine, a H1 receptor antagonist 강성권	view file
2018-02	Droplet digital PCR-based EGFR mutation detection with an internal quality control index to determine the quality of DNA 김성수	view file
2017-09	EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release Suh, Koung Jin; Sung, Ji Hea; Kim, Jin Won; Han, Song-Hee; Lee, Hye Seung; Min, Ahrum; Kang, Mi Hyun; Kim, Ji Eun; Kim, Ji-Won; Kim, Se Hyun; Lee, Jeong-Ok; Kim, Yu Jung; Lee, Keun-Wook; Kim, Jee Hyun; Bang, Soo-Mee; Im, Seock-Ah; Lee, Jong Seok Oncotarget, Vol.8 No.38, pp.63901-63910	DOI
2017-08	Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer Kwak, Yoonjin; Yun, Sumi; Nam, Soo Kyung; Seo, An Na; Lee, Kyu Sang; Shin, Eun; Oh, Heung-Kwon; Kim, Duck Woo; Kang, Sung Bum; Kim, Woo Ho; Lee, Hye Seung Journal of Translational Medicine, 15(1):167	view file DOI
2017-08	Cantharidin induces apoptosis and suppresses cell migration and invasion of MDA-MB-231 human breast cancer cells through inhibition of EGFR-STAT3 signaling 박민경	view file
2017-05	KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer Park, Sehhoon; Kim, Ji-Yeon; Lee, Se-Hoon; Suh, Beomseok; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.32 No.3, pp.514-522	view file DOI
2017-02	(The) roles of osteopontin on gastric and hepatic carcinogenesis in mouse model 이수형	view file
2017-02	Proportion and clinical features of never-smokers with non-small cell lung cancer Cho, Jaeyoung; Choi, Sun Mi; Lee, Jinwoo; Lee, Chang-Hoon; Lee, Sang-Min; Kim, Dong-Wan; Yim, Jae-Joon; Kim, Young Tae; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Park, Young Sik Chinese Journal of Cancer, Vol.36 No.1, p. 20	view file DOI
2016-12	Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice Lee, Su-Hyung; Park, Jun-Won; Woo, Sang-Ho; Go, Du-Min; Kwon, Hyo-Jung; Jang, Ja-June; Kim, Dae-Yong Oncotarget, Vol.7 No.52, pp. 87219-87231	view file DOI
2016-04	Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma Ock, Chan-Young; Son, Bongjun; Keam, Bhumsuk; Lee, Seung-Youn; Moon, Jaewoo; Kwak, Hwanjong; Kim, Sehui; Kim, Tae Min; Jeon, Yoon Kyung; Kwon, Seong Keun; Hah, J. Hun; Lee, Se-Hoon; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.142 No.4, pp.873-883	DOI

1 2 3 4